Levetiracetam for the treatment of myoclonic neurotoxicity induced by amiodarone
Sign Up to like & getrecommendations! Published in 2020 at "HeartRhythm Case Reports"
DOI: 10.1016/j.hrcr.2020.04.010
Abstract: Amiodarone is a class III antiarrhythmic prescribed for atrial fibrillation and ventricular arrhythmias commonly associated with adverse events such as pulmonary toxicity, thyroid dysfunction, QT prolongation, corneal opacities and rarely, myoclonic neurological toxicity. Those events… read more here.
Keywords: treatment myoclonic; levetiracetam treatment; myoclonic neurotoxicity; induced amiodarone ... See more keywords
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.14674
Abstract: Mutations in leucine‐rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD). The LRRK2 physiological and pathological function is still debated. However, different experimental evidence based on LRRK2 cellular localization… read more here.
Keywords: protein; pathological mutant; treatment; levetiracetam treatment ... See more keywords
Clinical Evaluation of Levetiracetam in the Treatment of Epilepsy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Healthcare Engineering"
DOI: 10.1155/2022/3789516
Abstract: Objectives Epilepsy is a chronic neurological disorder that is characterized by episodes of seizure. Methods In this study, patients with status epilepticus in the Intensive Care Unit of the Department of Neurology of Qujing First… read more here.
Keywords: evaluation levetiracetam; sodium valproate; abnormal discharge; levetiracetam ... See more keywords